1.Reoperations after Aortic Surgery.
Journal of the Korean Society for Vascular Surgery 2000;16(2):274-282
No abstract available.
2.Surgical Treatment of Primary Varicose Vein.
Journal of the Korean Society for Vascular Surgery 2001;17(1):136-144
No abstract available.
Varicose Veins*
3.Complications Associated with Surgical Treatment of Moyamoya Disease and Their Management.
Hyun Wook LEE ; Seung Chyul HONG
Journal of Korean Neurosurgical Society 2000;29(8):1136-1139
No abstract available.
Moyamoya Disease*
4.A clinical experience of acromioclavicular dislocation.
Gang Wook LEE ; Seung Hwan LEE
The Journal of the Korean Orthopaedic Association 1992;27(5):1374-1380
No abstract available.
Dislocations*
5.GB Opacification at CT by Contrast Media Injected a Few Hours Earlier in Adult with Normal Renal Function.
Seung Hyup KIM ; Kyung Mo YEON ; Jae Wook RYOO
Journal of the Korean Radiological Society 1994;31(1):135-138
PURPOSE: To evaluate the incidence of GB opacification, seen at CT, by contrast media injected a few hours earlier in adults with normal renal function and to assess the clinical significance of the opacification. MATERIAL AND METHODS: Seventeen patients with normal renal function were included in this study. Contrast enhanced CT scan was performed 4-13 hours after intravenous urography. As a control group, 17 patients in whom contrast media was not used in recent three days were included. The incidence of GB opacification and CT number of the GB were compared between 17 study patients and 17 control patients. RESULT: GB opacification(either homogeneous opacification or layering of contrast media and bile) was seen in 16 of 17 study patients(94%). GB was not opacified in any one of the control group. The mean CT number of GB was 174 HU in study patients, and was 27.3 HU in control patients. CONCLUSION:GB opacification seen at CT several hours after injection of water soluble contrast media seems to be a physiologic phenomenon, and that phenomenon should not be considered as a vicarious excretion due to impaired renal function.
Adult*
;
Contrast Media*
;
Humans
;
Incidence
;
Tomography, X-Ray Computed
;
Urography
6.An immunohistochemical study on prolactin and growth hormone-specific cells in the mice adenohypophyses during the estrous cycle.
Jong Hak LEE ; Won Young PAIK ; Seung Wook KIM
Korean Journal of Obstetrics and Gynecology 1991;34(10):1388-1399
No abstract available.
Animals
;
Estrous Cycle*
;
Mice*
;
Pituitary Gland, Anterior*
;
Prolactin*
7.Decubitoma: A Pseudosarcoma in Decubitus: Report of a case.
Hye Seung HAN ; Yong Il KIM ; Jeong Wook SEO
Korean Journal of Pathology 1996;30(11):1060-1064
Decubitus ulcer is often seen in the skin and underlying tissue of debilitated or immobilized patients as the result of prolonged pressure and impaired circulation. It manifests chiefly as an ulcer over bony prominences, but tumefaction is an extremely unusual presentation. A 53-year old male, a paralytic of the lower extremity for 18 years, developed a recurrent decubital ulcer despite repeated surgical repair, from which a rapidly growing, large fungating mass grew within a month. The last resected mass was bosselated and measured 15x9x3 cm with a major area of cicatrix-like induration, interdigitated with skeletal muscle bundles at the central area. Microscopically, the mass was composed of an upper half of active granulation tissue layer and a deeper half of dense, poorly cellular, fibrocollagenous bundles admixed with florid proliferation of atypical fibroblasts, but the absence of mitosis and the multifocal admixture of active inflammatory process-granulation tissue formation seemed to help exclude genuine fibromatosis, nodular fasciitis or proliferative myositis. We assume that this rapidly growing pseudofibromatosis is an additional manifestation of a prolonged decubitus ulcer, possibly related to the modified reparative process of decubitus ulcer following repeated excisions, for which we propose a term of decubitoma.
8.The Endocrine Manifestations and Growth of the Patients with 22q11.2 Microdeletion Syndrome.
Jong Seung LEE ; Jin Ho CHOI ; Han Wook YOO
Journal of Korean Society of Pediatric Endocrinology 2004;9(1):66-71
PURPOSE:Varying clinical phenotypes are associated with the chromosome 22q11.2 microdeletion syndrome. The endocrine manifestation are latent or overt hypoparathyroidism, thyroid dysfunction and short stature. This study was undertaken to investigate frequencies of endocrine abnormalities and short stature in patients with the chromosome 22q11.2 microdeletion syndrome. METHODS:Forty three unrelated patients were diagnosed having chromosome 22q11.2 microdeletion syndrome. Chromosomal microdeletion was confirmed by fluorescent in situ hybridation (FISH) with DNA probe (22q11.2 LSI TUPLE1 from Vysis). Serum total calcium and intact parathyroid hormone (PTH) were measured in all patients. Thyroid function tests including free thyroxine(T4), thyroid stimulating hormone (TSH) and thyroid autoantibodies were performed in all patients. Insulin-like growth factor-1 (IGF-1) was measured in 10 patients. Height, weight and body mass index were compared with chronological age in all patients. RESULTS:Seven patients (16%) had an overt hypoparathyroidism, presenting with hypocalcemic tetany. Thirteen patients (31%) showing hypocalcemia with normal PTH were regarded as having latent hypoparathyroidism since their PTH secretion response was blunted. Out of 2 patients with thyroid diseases, one patient had Graves disease and the other had Hashimoto thyroiditis. Five patients (12%) were below the 3rd percentile in height at evaluation. The BMI was below the 5th percentile in 23% of patients. CONCLUSION: Twenty patients (47%) presented with overt and latent hypoparathyroidism. Interestingly, autoimmune thyroid diseases such as Graves disease and Hashimoto thyroiditis were associated in patients with chromosome 22q11.2 microdeletion, indicating predisposition to autoimmune disorders. Therefore, a careful endocrine and growth evaluation is needed in these patients.
Autoantibodies
;
Body Mass Index
;
Calcium
;
DNA
;
Graves Disease
;
Hashimoto Disease
;
Humans
;
Hypocalcemia
;
Hypoparathyroidism
;
Parathyroid Hormone
;
Phenotype
;
Tetany
;
Thyroid Diseases
;
Thyroid Function Tests
;
Thyroid Gland
;
Thyrotropin
9.Mesenteric lymphadenitis due to Yersinia pseudotuberculosis 5b.
Myung Sook KOO ; Seung Ik AHN ; Byung Wook YOO
Korean Journal of Infectious Diseases 1993;25(3):253-258
No abstract available.
Mesenteric Lymphadenitis*
;
Yersinia pseudotuberculosis*
;
Yersinia*
10.Mesenteric lymphadenitis due to Yersinia pseudotuberculosis 5b.
Myung Sook KOO ; Seung Ik AHN ; Byung Wook YOO
Korean Journal of Infectious Diseases 1993;25(3):253-258
No abstract available.
Mesenteric Lymphadenitis*
;
Yersinia pseudotuberculosis*
;
Yersinia*